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Purpose: Two-millimeter punch biopsy is a swift and 
practical diagnostic tool in the outpatient setting. However, few 
studies have evaluated the efficacy of the method for diagnosis 
of malignant eyelid tumors.
Methods: This was an observational study of patients with 
suspicion of malignant eyelid tumor attending the Ocular 
Plastic Surgery Center at Hospital das Clínicas, University of 
São Paulo School of Medicine. Following standard procedures, 
preoperative biopsies were taken with a 2-mm trephine and 
surgical excision was performed with safety margins, followed 
by reconstruction. Anatomopathologic analysis of the surgical 
specimen was used as gold standard to evaluate the accuracy of 
diagnosis by punch biopsy.
Results: The study included 50 periocular tumors with 
suspicion of malignancy. The indicators of efficacy in the 
identification of malignancy by 2-mm punch biopsy were: 
sensitivity 88%, specificity 100%, positive predictive value 
100%, and negative predictive value 64%. Accuracy was 90% 
for malignancy and 80% for histologic type. The κ index of 
agreement between the diagnostic methods was 0.722 (p < 
0.001).
Conclusion: A positive result with 2-mm punch biopsy is 
a safe indication for surgical excision of the tumor, whereas a 
negative result does not necessarily imply benignity. In cases of 
high clinical suspicion, a second biopsy should be taken from a 
different part of the tumor to rule out malignancy.
(Ophthal Plast Reconstr Surg 2012;28:282–285)
Approximately 5% to 10% of all skin neoplasms affect the eyelid. In fact, periocular malignancy is the most common 
type of neoplasm observed at our service.1 Due to their small 
size, periocular tumors can be hard to diagnose and surgery is 
often postponed when clinical findings are ambiguous. Despite 
considerable accuracy in the diagnosis of malignancy, clinical 
evaluation of patients with periocular tumors frequently yield 
false-positive and false-negative results, and on the average 
clinical and histologic findings are poorly correlated.2–5
Several factors have been associated with recurrence 
of periocular tumors after treatment, such as size, location, 
and medical conditions related to histologic type.6 Aggressive 
tumors require larger surgical margins and pose a greater risk 
of metastasis.
Punch biopsy is a swift and simple diagnostic technique 
requiring very little equipment or surgical skill. A 2-mm tre-
phine will collect a tissue sample large enough for analysis and 
no suture is necessary. The level of agreement between punch 
biopsy, conventional incisional biopsy, and histopathologic 
analysis of the surgical specimen is high.7–9
Punch biopsy can be useful in preoperative assessments 
of skin disorders.7 However, the few published studies on 
punch biopsy in the periocular region—rarely cited by 
ophthalmologists—lack a complete evaluation of efficacy, espe-
cially with regard to histologic type.8,9
OBJECTIVE
The aim of this study was to evaluate the ability of 2-mm 
punch biopsy to diagnose malignancy and define the histologic 
type of eyelid tumors.
MATERIALS AND METHODS
This was an observational study of patients with eyelid tumors 
suspected for malignancy attending the Ocular Plastic Surgery Center 
of the Department of Ophthalmology, Hospital das Clínicas, University 
of São Paulo School of Medicine (HC-FMUSP), between November 
2007 and December 2010.
Tumors displaying clinical signs of malignancy on biomicros-
copy (changes in texture, color, and size associated with ulceration, 
raised and/or ulcerated surface, irregular outline, telangiectasias 
and/or loss of eyelashes) were included in the study. The study was 
previously approved by the research ethics committee of the institu-
tion (HC-FMUSP #1143/07) and was registered with ClinicalTrials.
gov under #NCT00865813. All patients gave their written informed 
consent.
Following standard procedures, preoperative biopsies were tak-
en from the most typical part of the tumor—usually a pearly patch or 
the border. The procedure which was done at the HC-FMUSP outpatient 
surgery service, included the following steps:
1. Instillation of anesthetic eyedrops.
2. Asepsis and antisepsis.
3. Placement of sterile drapes.
4. Infiltration of region with anesthetic solution containing adrena-
line at 1:200,000.
5. Insertion of a 2-mm stainless steel trephine (Richter) into the tu-
mor tissue by applying light pressure and rotation (Fig. 1A).
6. Exposure of the biopsied material using an insulin needle or 
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conjunctiva forceps, followed by severing of the biopsy specimen 
with a scalpel size 11 (Fig. 1B, C).
7. Placement of dressing with ophthalmological ointment contain-
ing 0.5% gentamicin (Allergan).
8. Biopsy material was secured in a labeled vial of 10% formalin 
(Fig. 1D).
Within 15 to 30 days, patients underwent surgical tumor excision with 
adequate safety margins, followed by reconstruction of the tumor site.
The histopathologic examination was performed at the 
Department of Pathology by pathologists masked to the biopsy results. 
Discordant slides were reviewed by a nonmasked pathologist.
Histopathologic analysis of the surgical specimen was used as 
gold standard to evaluate the accuracy of diagnosis by punch biopsy. 
The tumor type was determined histologically based on growth patterns 
in hematoxylin and eosin stains.
The performance standards of 2-mm punch biopsy were studied 
using histopathologic diagnosis of the totally excised tumor as the gold 
standard.
RESULTS
Fifty patients aged 29 to 90 years (average: 63) were evaluated, 
of whom 19 (38%) were men and 31 (62%) were women. Based on 
Fitzpatrick’s classification10 of skin type, 4 were Type I (8%), 14 Type II 
(28%), 20 Type III (40%), 10 Type IV (20%), and 2 were Type V (4%). 
The tumor was located either on the lower eyelid (n = 38; 76%), the 
inner corner (n = 8; 16%), or the upper eyelid (n = 4; 8%) (Table 1).
Tumors were malignant in 41 cases (82%) and benign in 9 
(18%). Basal cell carcinoma was predominant (n = 29; 71%) among 
malignant tumors, followed by squamous cell carcinoma (n = 10; 24%), 
and melanoma (n = 2; 5%). Melanocytic nevus was predominant (n = 5; 
56%) among the benign tumors, followed by granuloma (n = 2; 22%), 
molluscum contagiosum (n = 1; 11%), and squamous cell papilloma 
(n = 1; 11%).
Evaluation of Agreement for Diagnosis of Malignancy. Five cases 
diagnosed as benign in the biopsy were found to be malignant upon 
excision (false-negative) (Table 2).
Performance standards:
•	 Prevalence (pretest probability): 82%
•	 Sensitivity: 88%.
•	 Specificity: 100%.
•	 Postive predictive value: 100%.
•	 Negative predictive value: 64%.
•	 Accuracy: 90% for presence of malignancy.
•	 κ index: 0.722 (p < 0.001) (good level of agreement).
Evaluation of Agreement for Histologic Type. The 2 diagnostic meth-
ods disagreed with regard to histologic type in 10 of 50 cases (accuracy: 
80%). Five cases diagnosed as benign histologic type in the biopsy were 
found to be malignant upon excision (false-negative results). Four of 
the true-positive cases disagreed with regard to histologic type, despite 
agreement regarding malignancy. Among the true-negative cases, the 
identification of histologic type diverged for a single tumor diagnosed 
by both methods as benign (Table 3).
DISCUSSION
Todd et al.7 found a high level of agreement (94%) 
between 2-mm punch biopsy and elliptical incisional biopsy 
in different skin tumors. This finding and the simplicity of the 
procedure (no suture is required) has contributed to disseminate 
2-mm punch biopsy in dermatological practice.
In a retrospective study on periocular tumors, Rice et al.8 
evaluated the agreement between 2-mm punch biopsy, elliptical 
incisional biopsy, and histopathologic analysis of the surgical 
specimen. Agreement was 85% for punch biopsy and 95% for 
incisional biopsy. However, no other performance standards were 
reported.
The importance of 3-mm punch biopsy in the manage-
ment of periocular basal cell carcinoma was evaluated ret-
rospectively by Chatterjeeet al.9 Agreement was reasonable 
between clinical findings and punch biopsy (sensitivity 87.5%, 
specificity 75%, positive predictive value 87.5%, and negative 
Table 1. Sample characteristics
Gender
 Men 19 (38%)
 Women 31 (62%)
Average age 63 (29–90)
Fitzpatrick Classification
 Type I 4 (8%)
 Type II 14 (28%)
 Type III 20 (40%)
 Type IV 10 (20%)
 Type V 2 (4%)
Tumor site
 Lower eyelid 38 (76%)
 Inner corner 8 (16%)
 Upper eyelid 4 (8%)
Tumors 50
Benign 9 (18%)
 Nevus 5
 Granuloma 2
 Molluscum 1
 Papilloma 1
Malignant 41 (82%)
 BCC 29
 SCC 10
 Melanoma 2
BCC, basal cell carcinoma; SCC, squamous cell carcinoma.
Table 2. Correlation between 2-mm punch biopsy and 
anatomopathologic findings (malignancy diagnosis)
Excised specimen Malignant Benign Total
Biopsy Malignant 36 0 36
Benign 5 9 14
Total 41 9 50
Table 3. Accuracy with regard to histologic type
Biopsy Excised specimen
Actinic elastosis BCC
Granuloma BCC
Actinic keratosis Actinic keratosis + SCC
Actinic keratosis SCC
Actinic keratosis SCC
False-negative 5
Actinic keratosis Granuloma
True-negative 1
Actinic keratosis + SCC BCC
Tumor of skin appendages BCC
BCC SCC
SCC BCC
True-positive 4
Cases of disagreement 10
Accuracy 80%
BCC, basal cell carcinoma; SCC, squamous cell carcinoma.
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predictive value 75%). However, due to lack of specimens for 
analysis (only 13 of 24 patients underwent surgical excision), 
the 2 methods could not be compared with the gold standard.
Both 3-mm and 4-mm punch biopsy and elliptical incisional 
biopsy require 1 or 2 stitches to repair the site of sample collection. 
In contrast, 2-mm punch biopsy makes a suture unnecessary, 
saving time, surgical supplies, and resources.8
The main factor determining the usefulness of a diagnostic 
method is accuracy. In addition to a high level of accuracy (90%), 
2-mm punch biopsy displayed high levels of sensitivity (88%), 
specificity (100%), positive predictive value (100%), and nega-
tive predictive value (64%) for the diagnosis of malignant eyelid 
tumor.
Since clinical examinations can yield ambiguous results, 
confirmation of malignancy by 2-mm punch biopsy is a useful aid 
in the choice of surgical approach. Patients with early malignant 
eyelid tumors are not uncommonly misdiagnosed with trichiasis, 
blepharitis, meibomitis, and other inflammatory conditions. A 
100% specificity means no false-positive results, thus no unneces-
sary surgery. A simple biopsy can change the course of the disease 
by serving as a guide in the treatment of a malignant tumor.
The high level of reliability (κ = 0.722) in the evalua-
tion of agreement between 2-mm punch biopsy and histopatho-
logic analysis rules out chance as the explanation of the results. 
Accuracy was greater for the presence of malignancy (90%) 
than for histologic type (80%)
Areas with precursor lesions such as actinic elastosis, actinic 
keratosis, and inflammatory infiltrate can lead to false-negative 
results for malignancy (Table 3). This is reflected by the fact that 
negative predictive value was lower (64%) than the other indices. 
Thus—confirming observations made by other authors8in cases 
of high clinical suspicion and negative findings for malignancy, a 
second biopsy should be taken from a different part of the tumor.
The main limitation of the technique is sample size, 
which can compromize the identification of the tumor histologic 
type as showed in Figure 2.
FIG. 1. A, Patient with ulcerated lesion; B, punch biopsy: small lobules of atypical basaloid cells showing invasion of the superficial 
and middle dermis (white arrow). Hematoxylin-eosin (x200), overall view; C, surgical specimen. At the periphery (white arrow) areas 
with keratinization and a basaloid aspect; however, in the center (black arrow), the squamous nature of the tumor is apparent. Hema-
toxylin-eosin (X200).
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The present study shows that a positive result with 
2-mm punch biopsy is a safe indication for surgical exci-
sion of the tumor (Table 3), whereas a negative result does 
not necessarily imply benignity. In this study of 50 patients, 
the false-negative rate was 12% (1 − sensitivity), suggest-
ing about 1 in 10 clinically suspicious malignancies of the 
eyelid may be missed with a 2-mm punch biopsy. Therefore, 
in cases of high clinical suspicion, if the clinical impres-
sion does not fit the histopathologic diagnosis, perform 
biopsy again from a different part of the tumor to rule out 
malignancy. 
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FIG. 2. A, Insertion of a 2-mm stainless steel trephine into the tumor tissue by applying light pressure and rotation. B, Exposure of 
the biopsied material using a conjunctiva forceps. C, Followed by severing of the biopsy specimen with a scalpel size 11. D, Biopsy 
material was secured in a labeled vial of 10 formalin.
